Loading...

Valerie Gruber, PhD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentPsychiatry
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-206-3943
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Kent State UniversityPh.D.1990Clinical Psychology
    UC BerkeleyM.P.H.1992School of Public Health
    Collapse Awards and Honors
    UCSF Clinical Psychology Training Program2014David Rea Training Award

    Collapse Overview 
    Collapse Overview
    VALERIE A. GRUBER is Professor in the Department of Psychiatry at UCSF, and faculty in the Public Service and Minorities Track of the UCSF Clinical Psychology Training Program. Dr. Gruber is a licensed psychologist, and holds an APA certificate in the treatment of alcohol and other substance use disorders. She completed a Ph.D. in Clinical Psychology at Kent State University, internship at the UCSF Clinical Psychology Training Program, and an M.P.H. at the University of California Berkeley. Her clinical, supervision, leadership, teaching and research efforts focus on developing clinical interventions for substance use disorders and associated medical conditions that are effective for low-income, culturally diverse substance users. Areas of expertise include trauma-informed integrated treatment of substance use health conditions in behavioral health and primary care settings. Skills include motivational interviewing, individual, couples and group psychotherapy, psychological assessment, cultural competence, staff development, program management and clinical research.


    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chang JS, Chiu JD, Gruber VA, Sorensen JL. Fair hearing outcomes of patients recommended discharge from methadone maintenance. J Subst Abuse Treat. 2017 Dec; 83:68-72. PMID: 28919058.
      View in: PubMed
    2. Guydish J, Tajima B, Le T, Henderson C, Yip D, Gruber V, Garcia W, Delucchi KL. Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control. 2018 Jan; 27(1):43-49. PMID: 27913790.
      View in: PubMed
    3. Guydish J, Gruber VA, Le T, Tajima B, Andrews KB, Leo H, Zura SK, Miller R, Tsoh JY. A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment. J Subst Abuse Treat. 2016 Apr; 63:39-45. PMID: 26825975; PMCID: PMC4775306 [Available on 04/01/17].
      View in: PubMed, PubMed Central
    4. Kyle TL, Horigian VE, Tross S, Gruber VA, Pereyra M, Mandler RN, Feaster DJ, Metsch LR. Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS Behav. 2015 Mar; 19(3):536-42. PMID: 25074737; PMCID: PMC4312252.
      View in: PubMed, PubMed Central
    5. Carrico AW, Flentje A, Gruber VA, Woods WJ, Discepola MV, Dilworth SE, Neilands TB, Jain J, Siever MD. Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men. J Urban Health. 2014 Jun; 91(3):555-67. PMID: 24744105; PMCID: PMC4074324.
      View in: PubMed, PubMed Central
    6. McCance-Katz EF, Gruber VA, Beatty G, Lum P, Ma Q, DiFrancesco R, Hochreiter J, Wallace PK, Faiman MD, Morse GD. Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism. Am J Addict. 2014 Mar-Apr; 23(2):137-44. PMID: 24118434; PMCID: PMC3984379.
      View in: PubMed, PubMed Central
    7. Gruber VA, Rainey PM, Lum PJ, Beatty GW, Aweeka FT, McCance-Katz EF. Interactions between alcohol and the HIV entry inhibitor Maraviroc. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):375-7. PMID: 23881910; PMCID: PMC4100473.
      View in: PubMed, PubMed Central
    8. McCance-Katz EF, Gruber VA, Beatty G, Lum PJ, Rainey PM. Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. J Addict Med. 2013 Jul-Aug; 7(4):264-70. PMID: 23666322; PMCID: PMC3737351.
      View in: PubMed, PubMed Central
    9. Sorensen JL, Haug NA, Larios S, Gruber VA, Tulsky J, Powelson E, Logan DP, Shapiro B. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J Subst Abuse Treat. 2012 Dec; 43(4):418-23. PMID: 23007110; PMCID: PMC3484182.
      View in: PubMed, PubMed Central
    10. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 01; 60(3):282-8. PMID: 22495786; PMCID: PMC3723399.
      View in: PubMed, PubMed Central
    11. Gruber VA, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin Infect Dis. 2012 Feb 01; 54(3):414-23. PMID: 22100576; PMCID: PMC3258270.
      View in: PubMed, PubMed Central
    12. Gruber VA, McCance-Katz EF. Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV/AIDS Rep. 2010 Aug; 7(3):152-60. PMID: 20532839; PMCID: PMC2892618.
      View in: PubMed, PubMed Central
    13. Kahn R, Biswas K, Childress AR, Shoptaw S, Fudala PJ, Gorgon L, Montoya I, Collins J, McSherry F, Li SH, Chiang N, Alathari H, Watson D, Liberto J, Beresford T, Stock C, Wallace C, Gruber V, Elkashef A. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend. 2009 Jul 01; 103(1-2):59-64. PMID: 19414226.
      View in: PubMed
    14. Gruber VA, Delucchi KL, Kielstein A, Batki SL. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):199-206. PMID: 18243585; PMCID: PMC2821580.
      View in: PubMed, PubMed Central
    15. Haug NA, Shopshire M, Tajima B, Gruber V, Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ. 2008; 38(2):181-92. PMID: 18724657; PMCID: PMC2742313.
      View in: PubMed, PubMed Central
    16. Haug NA, Sorensen JL, Gruber VA, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006 Nov; 30(6):752-81. PMID: 17050764.
      View in: PubMed
    17. Sorensen JL, Haug NA, Delucchi KL, Gruber V, Kletter E, Batki SL, Tulsky JP, Barnett P, Hall S. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007 Apr 17; 88(1):54-63. PMID: 17056206; PMCID: PMC1976289.
      View in: PubMed, PubMed Central
    18. Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002 May 01; 66(3):283-93. PMID: 12062463.
      View in: PubMed
    Valerie's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (118) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (14) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑